Ads
related to: Pfizer
Search results
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoPfizer stock is trading at a nine-year low as the drugmaker looks for its next big break after...
Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers.
Forbes· 15 hours agoYou might think that a big, well-known healthcare firm offering a 6.6% dividend would attract investors. The drug maker is a big one with a market capitalization of $143 billion and average ...
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Zacks via Yahoo Finance· 7 hours agoPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Pfizer accused of ‘bringing discredit’ on pharmaceutical industry after Covid social media posts
The Telegraph via Yahoo News· 2 weeks agoPfizer has been accused by the UK’s pharmaceutical watchdog of “bringing discredit” on the industry...
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 1 day agoIf you had bought $1,000 worth of Pfizer (NYSE: PFE) shares five years ago, how much would that be...
FDA expands Pfizer boosters for more teens as omicron surges
AOL· 13 hours agoThe U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12. Boosters ...
Where Will Pfizer Stock Be in 10 Years?
Motley Fool via Yahoo Finance· 1 week agoPfizer (NYSE: PFE) stock has been struggling for a while now. In the past 12 months, it has declined by 36%. A lack of growth recently, a dependence on...
Is Pfizer Stock a Buy?
Motley Fool via Yahoo Finance· 4 days agoPfizer (NYSE: PFE) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on hopes for its coronavirus...
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
CNBC· 1 week agoA vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk...
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth (NYSE:PFE)
Seeking Alpha· 9 hours agoAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the...